(Bloomberg) -- Canadian health authorities authorized Pfizer Inc.’s Covid-19 shot for children age 5 to 11, opening the door for a new phase of the country’s vaccination drive.
Health Canada on Friday announced it has approved a lower dose of Pfizer Inc. and BioNTech SE‘s Covid-19 vaccine for all school-age children.
“After a thorough and independent scientific review of the evidence, the department has determined that the benefits of this vaccine for children between 5 and 11 years of age outweigh the risks,” according to a statement.
About 85% of Canadians aged 12 and older are fully vaccinated.
